1986
DOI: 10.1016/0091-6749(86)90184-3
|View full text |Cite
|
Sign up to set email alerts
|

Immunotherapy with cat- and dog-dander extracts II. In vivo and in vitro immunologic effects observed in a 1-year double-blind placebo study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
40
1

Year Published

1989
1989
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 92 publications
(43 citation statements)
references
References 38 publications
2
40
1
Order By: Relevance
“…The changes in IgG4 concentrations observed here in a clinically effective treatment regimen were statistically significant but modest compared to those reported in some immunotherapy studies (1.4- to 2.8-fold). This most likely relates to the allergen dose used, as a dose-response effect has been reported, and the changes we detected were similar to those seen for other immunotherapy regimens such as for Alternaria [24], cat [25] or house dust mite [26]. Notably, not all patients showed an increase in allergen-specific IgG4 after immunotherapy with Dpg-Pol extract at this dose.…”
Section: Discussionmentioning
confidence: 61%
“…The changes in IgG4 concentrations observed here in a clinically effective treatment regimen were statistically significant but modest compared to those reported in some immunotherapy studies (1.4- to 2.8-fold). This most likely relates to the allergen dose used, as a dose-response effect has been reported, and the changes we detected were similar to those seen for other immunotherapy regimens such as for Alternaria [24], cat [25] or house dust mite [26]. Notably, not all patients showed an increase in allergen-specific IgG4 after immunotherapy with Dpg-Pol extract at this dose.…”
Section: Discussionmentioning
confidence: 61%
“…1,2 Drugs that are used to treat allergies, such as antihistamines or corticosteroids, ameliorate symptoms but do not stop progression; the only therapy that modifies progression of allergies is allergen-specific immunotherapy (SIT). SIT has major disadvantages, however, in that it requires numerous allergen administrations over 3 to 5 years 3,4 and can cause severe adverse events that range from local allergic reactions to anaphylaxis. 5 SIT has been reported to modify different aspects of the immune system, inducing a shift of allergy-promoting T H 2 cells to T H 1 cells, 6 epitope-specific T-cell anergy, 7 and allergen-specific regulatory T cells that suppress the responses of effector T cells.…”
mentioning
confidence: 99%
“…It was previously thought that loss of a seasonal rise in serum IgE antibody levels and/or the formation of IgGblocking antibodies mediated hyposensitization of various allergic diseases [3][4][5]. Although a significant overall association between changes of antibody levels after hyposensitization and clinical effects has been found, there are always a considerable number of exceptions [6,7]. Meanwhile, in vitro studies revealed that T-lymphocyte anergy could be the main system of hyposensitization [8][9][10], indicating the possibility that modulated functions of T lymphocytes are involved in the mechanism of hyposensitization.…”
Section: Introductionmentioning
confidence: 90%
“…Regarding the humoral immune response, suppression of IgE production was demonstrated in patients with hay fever [30] and in mice treated with modified allergens [23]. Increased levels of IgG-blocking antibody have been demonstrated in patients with bronchial asthma [6], hay fever [7], and perennial rhinitis [5]. However, changes in the levels of these antibodies do not seem to fully account for the suppression of symptoms [6,7].…”
Section: Oa-specific Ige Levelsmentioning
confidence: 99%
See 1 more Smart Citation